---
title: "The Mexican president talks about local pharmaceutical production, U.S. pharmaceutical stocks maintain their upward trend, and the Mexican peso gives back its gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242433493.md"
description: "Mexican President López Obrador announced plans to increase domestic pharmaceutical production, with a plan to invite bids for companies to manufacture drugs in Mexico starting in 2026. Meanwhile, the Mexican peso's appreciation against the US dollar narrowed to 1.2%, and it fell back to 19.36 pesos after the release of US GDP data. The gains of US pharmaceutical stocks such as Pfizer and Moderna also decreased"
datetime: "2025-05-29T14:38:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242433493.md)
  - [en](https://longbridge.com/en/news/242433493.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242433493.md)
generator: "portal-rs"
---

# The Mexican president talks about local pharmaceutical production, U.S. pharmaceutical stocks maintain their upward trend, and the Mexican peso gives back its gains

Mexican President López Obrador stated that Mexico will increase pharmaceutical production and reduce imports.

Starting from 2026, Mexico will invite bids from companies to manufacture drugs locally.

The Mexican side will observe the impact of the U.S. trade court's tariff ruling (triggered by President Trump) on the scope of its effects.

The Mexican side is aware that the U.S. government will appeal the trade court's tariff ruling.

The Mexican side does not recognize the decisions made by the Trump administration regarding international students studying in the U.S.

The Mexican peso's appreciation against the U.S. dollar narrowed to 1.2%, retreating below 19.36 pesos, after rising to 19.3089 pesos, refreshing the daily high, following the release of U.S. GDP data at 20:30 Beijing time.

The Mexican stock index turned negative, moving away from the daily high refreshed at the beginning of U.S. trading.

Pfizer's stock increase narrowed to less than 0.8%, Moderna's increase narrowed to less than 0.9%, while Novavax rose over 2.5%, refreshing the daily high

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)

## Related News & Research

- [Moderna (NASDAQ:MRNA) Insider Sells $485,766.45 in Stock](https://longbridge.com/en/news/297959605.md)
- [Moderna Chief Legal Officer Shannon Thyme Klinger disposes of USD 485,271.45 in common shares](https://longbridge.com/en/news/297958452.md)
- [Medicus Pharma signs co-development, licensing deal with Pfizer for CD228V antibody-drug conjugate](https://longbridge.com/en/news/297910433.md)
- [Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement](https://longbridge.com/en/news/297195128.md)
- [This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday](https://longbridge.com/en/news/297353340.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**